SAMANTHA DE BRUYN KOPS: Open Payments
NPI 1730744947 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 68 payments from 12 companies in 2025. Trend: 2023 $1,389 · 2024 $1,778 · 2025 $1,867
Food & beverage: $1,867
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $318 |
| Novo Nordisk Inc | 9 | $296 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $216 |
| Corcept Therapeutics | 6 | $191 |
| AstraZeneca Pharmaceuticals LP | 2 | $189 |
| Lilly USA, LLC | 8 | $155 |
| Vanda Pharmaceuticals Inc. | 2 | $141 |
| ABBVIE INC. | 5 | $105 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Phathom Pharmaceuticals, Inc. | 2 | $85 |
Products named: CAPLYTA, Korlym, AIRSUPRA, Wegovy, FANAPT, EVENITY, REPATHA, LEQVIO.
Industry payments across ID — which companies pay providers there.
